Kedrion SpA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kedrion SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5144
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company’s products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products for the treatment of orphan diseases. Kedrion also offers contract manufacturing services, technology transfer services and biological safety center services. The company works in partnership with Italian National Health Service to achieve self-sufficiency in plasma-derived therapies. It has manufacturing plants in Italy, Hungary and the US. The company has operational presence in Asia, Europe, North America and South America. Kedrion is headquartered in Barga, Lucca, Italy.

Kedrion SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kedrion SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kedrion SpA, Medical Devices Deals, 2012 to YTD 2018 10
Kedrion SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Kedrion SpA, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Kedrion Acquires RhoGAM Line Of Products From Ortho-Clinical Diagnostics 12
Partnerships 13
National Immunobiological, Pharmstandard and Kedrion Biopharma form Joint Venture 13
Biotest Pharma Enters into Distribution Agreement with Kedrion Biopharma 14
Licensing Agreements 15
United Biotech Enters into Licensing Agreement with Kedrion 15
Debt Offering 16
Kedrion Raises USD397 Million in Public Offering of 3% Bonds Due 2022 16
Kedrion Raises USD514 Million in Private Placement of Bonds 17
Acquisition 18
Kedrion Completes Acquisition Of Somerset Labs From Ortho-Clinical Diagnostics 18
Fondo Strategico Italiano Acquires 18.6% Stake In Kedrion From Sestant For US$188 Million 19
Kedrion SpA – Key Competitors 20
Kedrion SpA – Key Employees 21
Kedrion SpA – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Kedrion SpA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kedrion SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kedrion SpA, Deals By Therapy Area, 2012 to YTD 2018 8
Kedrion SpA, Medical Devices Deals, 2012 to YTD 2018 10
Kedrion SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Kedrion Acquires RhoGAM Line Of Products From Ortho-Clinical Diagnostics 12
National Immunobiological, Pharmstandard and Kedrion Biopharma form Joint Venture 13
Biotest Pharma Enters into Distribution Agreement with Kedrion Biopharma 14
United Biotech Enters into Licensing Agreement with Kedrion 15
Kedrion Raises USD397 Million in Public Offering of 3% Bonds Due 2022 16
Kedrion Raises USD514 Million in Private Placement of Bonds 17
Kedrion Completes Acquisition Of Somerset Labs From Ortho-Clinical Diagnostics 18
Fondo Strategico Italiano Acquires 18.6% Stake In Kedrion From Sestant For US$188 Million 19
Kedrion SpA, Key Competitors 20
Kedrion SpA, Key Employees 21
Kedrion SpA, Subsidiaries 22

List of Figures
Kedrion SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kedrion SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kedrion SpA, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Kedrion SpA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invenra Inc-製薬・医療分野:企業M&A・提携分析
    Summary Invenra Inc (Invenra) is a healthcare services provider that offers therapeutic solutions. The company discovers therapeutic human antibodies and their derivatives. It uses its proprietary technology to combine the ribosome display, cell free expression of antibodies with miniaturization, mi …
  • Harsco Corp:企業の戦略・SWOT・財務情報
    Harsco Corp - Strategy, SWOT and Corporate Finance Report Summary Harsco Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • United Therapeutics Corp (UTHR)-医療機器分野:企業M&A・提携分析
    Summary United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues including Remodulin (tre …
  • INRIX, Inc.:企業の戦略・SWOT・財務情報
    INRIX, Inc. - Strategy, SWOT and Corporate Finance Report Summary INRIX, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • C&D Technologies Inc:企業の戦略的SWOT分析
    C&D Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Iron Mountain Incorporated:企業の戦略・SWOT・財務情報
    Iron Mountain Incorporated - Strategy, SWOT and Corporate Finance Report Summary Iron Mountain Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • EarlySense Inc-医療機器分野:企業M&A・提携分析
    Summary EarlySense Inc (EarlySense), a subsidiary of Earlysense Ltd is a medical device company that offers patient care systems. The company offers continuous patient monitoring for heart rate, respiratory rate and motion. It provides central display station, hallway screen, bedside unit, and conta …
  • Air India Ltd.:企業の戦略・SWOT・財務分析
    Air India Ltd. - Strategy, SWOT and Corporate Finance Report Summary Air India Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Anaconda Mining Inc:企業の戦略・SWOT・財務分析
    Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Itochu Corporation (8001)-エネルギー分野:企業M&A・提携分析
    Summary Itochu Corporation (Itochu) is a trading company. It offers domestic trading, import and export, and overseas trading. The company trades in products such as textile, machinery, metals, minerals, energy, chemicals, food, general products, information and communications technology, realty, in …
  • Allianz Group:企業のM&A・事業提携・投資動向
    Allianz Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allianz Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • MLP SE (MLP):企業の財務・戦略的SWOT分析
    MLP SE (MLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Incitec Pivot Ltd (IPL):企業の財務・戦略的SWOT分析
    Incitec Pivot Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Molecular Templates Inc:企業のM&A・事業提携・投資動向
    Molecular Templates Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Molecular Templates Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Diagenode sa-医療機器分野:企業M&A・提携分析
    Summary Diagenode sa (Diagenode) is a provider of biological sample preparation, epigenetics research, and diagnostics assays. The company offers Bioruptor shearing and IP-star automation instruments, reagent kits, and antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. Its produ …
  • Service Corporation International (SCI):企業の財務・戦略的SWOT分析
    Service Corporation International (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Tox Free Solutions Limited (TOX):企業の財務・戦略的SWOT分析
    Tox Free Solutions Limited (TOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Phoenix Petroleum Philippines Inc (PNX):石油・ガス:M&Aディール及び事業提携情報
    Summary Phoenix Petroleum Philippines Inc (PNX) is an independent oil and gas company that distributes petroleum products and lubricants. The company provides automotive fuels, biodiesel, gasoline and aviation fuels, among others. It offers services such as trading of refined petroleum products and …
  • Tallgrass Energy Partners LP (TEP):石油・ガス:M&Aディール及び事業提携情報
    Summary Tallgrass Energy Partners LP (Tallgrass Energy), a midstream oil and gas company.. It offers natural gas transportation and storage services to customers in the Rocky Mountains and Midwest regions of the US. The company also provides crude oil transportation to customers in Wyoming, Colorado …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆